Sesamin is one of the major precursors of mammalian lignans in sesame seed (Sesamum indicum) as observed in vitro and in rats

Journal of Nutrition

Volumn 136, Issue 4, 2006, Pages 906-912

  Liu, Zhen ^a   Saarinen, Niina M ^a,b   Thompson, Lilian U ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Mammalian lignans; Metabolism; Sesame lignans; Sesame seed; Sesamin

Indexed keywords

LIGNAN; SESAMIN;

ARTICLE; FEMALE; IN VITRO STUDY; LINSEED; MAMMAL CELL; NONHUMAN; PLANT METABOLISM; PRECURSOR; RAT; RAT STRAIN; SESAME; URINALYSIS;

MAMMALIA; SESAMUM INDICUM;

EID: 33645530876     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/136.4.906     Document Type: Article

References (51)

1. Adlercreutz H, Mazur W. Phyto-oestrogens and Western diseases. Ann Med. 1997;29:95-120.
2. Thompson LU. Flaxseed, lignans, and cancer. In: Thompson LU, Cunnane SC, editors. Flaxseed in human nutrition, 2nd ed. Champaign (IL): AOCS Press; 2003. p. 194-222.
3. Heinonen S, Nurmi T, Liukkonen K, Poutanen K, Wähälä K, Deyama T, Nishibe S, Adlercreutz H. In vitro metabolism of lignans: new precursors of mammalian lignans enterolactone and enterodiol. J Agric Food Chem. 2001;49:3178-86.
4. Saarinen NM, Warri A, Mäkelä SI, Eckerman C, Reunanen M, Ahotupa M, Salmi SM, Franke AA, Kangas L, Santti R. Hydroxymatairesinol, a novel enterolactone precursor with antitumor properties from coniferous tree (Picea abies). Nutr Cancer. 2000;36:207-16.
5. Axelson M, Sjovall J, Gustafsson BE, Setchell KD. Origin of lignans in mammals and identification of a precursor from plants. Nature. 1982;298:659-60.
6. Borriello SP, Setchell KD, Axelson M, Lawson AM. Production and metabolism of lignans by the human faecal flora. J Appl Bacteriol. 1985;58:37-43.
7. Setchell KD, Lawson AM, Mitchell FL, Adlercreutz H, Kirk DN, Axelson M. Lignans in man and in animal species. Nature. 1980;287:740-2.
8. Wang LQ, Meselhy MR, Li Y, Qin GW, Hattori M. Human intestinal bacteria capable of transforming secoisolariciresinol diglucoside to mammalian lignans, enterodiol and enterolactone. Chem Pharm Bull (Tokyo). 2000;48:1606-10.
9. Wang LQ, Meselhy MR, Li Y, Nakamura N, Min BS, Qin GW, Hattori M. The heterocyclic ring fission and dehydroxylation of catechins and related compounds by Eubacterium sp. strain SDG-2, a human intestinal bacterium. Chem Pharm Bull (Tokyo). 2001;49:1640-3.
10. Thompson LU, Robb P, Serraino M, Cheung F. Mammalian lignan production from various foods. Nutr Cancer. 1991;16:43-52.
11. Mazur W, Fotsis T, Wähälä K, Ojala S, Salakka A, Adlercreutz H. Isotope dilution gas chromatographic-mass spectrometric method for the determination of isoflavonoids, coumestrol, and lignans in food samples. Anal Biochem. 1996;233:169-80.
12. Fukuda Y, Osawa T, Namiki M, Saki T. Studies on antioxidative substances in sesame. Agric Biol Chem. 1985;49:301-6.
13. Katsuzaki H, Kawakishi S, Osawa T. Sesaminol glucosides in sesame seeds. Phytochemistry. 1994;35:773-6.
14. Hirose N, Inoue T, Nishihara K, Sugano M, Akimoto K, Shimizu S, Yamada H. Inhibition of cholesterol absorption and synthesis in rats by sesamin. J Lipid Res. 1991;32:629-38.
15. Ogawa H, Sasagawa S, Murakami T, Yoshizumi H. Sesame lignans modulate cholesterol metabolism in the stroke-prone spontaneously hypertensive rat. Clin Exp Pharmacol Physiol Suppl. 1995;22:S310-2.
16. Hirata F, Fujita K, Ishikura Y, Hosoda K, Ishikawa T, Nakamura H. Hypocholesterolemic effect of sesame lignan in humans. Atherosclerosis. 1996; 122:135-6.
17. Matsumura Y, Kita S, Morimoto S, Akimoto K, Furuya M, Oka N, Tanaka T. Antihypertensive effect of sesamin. I. protection against deoxycorticosterone acetate-salt-induced hypertension and cardiovascular hypertrophy. Biol Pharm Bull. 1995;18:1016-9.
18. Kita S, Matsumura Y, Morimoto S, Akimoto K, Furuya M, Oka N, Tanaka T. Antihypertensive effect of sesamin. II. protection against two-kidney, one-clip renal hypertension and cardiovascular hypertrophy. Biol Pharm Bull. 1995;18:1283-5.
19. Matsumura Y, Kita S, Tanida Y, Taguchi Y, Morimoto S, Akimoto K, Tanaka T. Antihypertensive effect of sesamin. III. protection against development and maintenance of hypertension in stroke-prone spontaneously hypertensive rats. Biol Pharm Bull. 1998;21:469-73.
20. Nakano D, Itoh C, Takaoka M, Kiso Y, Tanaka T, Matsumura Y. Antihypertensive effect of sesamin. IV. inhibition of vascular superoxide production by sesamin. Biol Pharm Bull. 2002;25:1247-9.
21. Hirose N, Doi F, Ueki T, Akazawa K, Chijiiwa K, Sugano M, Akimoto K, Shimizu S, Yamada H. Suppressive effect of sesamin against 7,12-dimethylbenz[ a]-anthracene induced rat mammary carcinogenesis. Anticancer Res. 1992; 12:1259-65.
22. Miyahara Y, Komiya T, Katsuzaki H, Imai K, Nakagawa M, Ishi Y, Hibasami H. Sesamin and episesamin induce apoptosis in human lymphoid leukemia Molt 4B cells. Int J Mol Med. 2000;6:43-6.
23. Nakai M, Harada M, Nakahara K, Akimoto K, Shibata H, Miki W, Kiso Y. Novel antioxidative metabolites in rat liver with ingested sesamin. J Agric Food Chem. 2003;51:1666-70.
24. Kiso Y. Antioxidative roles of sesamin, a functional lignan in sesame seed, and it's effect on lipid- and alcohol-metabolism in the liver: a DNA microarray study. Biofactors. 2004;21:191-6.
25. Miyake Y, Fukumoto S, Okada M, Sakaida K, Nakamura Y, Osawa T. Antioxidative catechol lignans converted from sesamin and sesaminol triglucoside by culturing with Aspergillus. J Agric Food Chem. 2005;53:22-7.
26. Penalvo JL, Heinonen SM, Aura AM, Adlercreutz H. Dietary sesamin is converted to enterolactone in humans. J Nutr. 2005;135:1056-62.
27. Coulman KD, Liu Z, Hum WQ, Michaelides J, Thompson LU. Whole sesame seed is as rich a source of mammalian lignan precursors as whole flaxseed. Nutr Cancer. 2005;52:156-65.
28. Umeda-Sawada R, Ogawa M, Igarashi O. The metabolism and distribution of sesame lignans (sesamin and episesamin) in rats. Lipids. 1999;34:633-7.
29. Thompson LU, Seidl MM, Rickard SE, Orcheson LJ, Fong HHS. Antitumorigenic effect of a mammalian lignan precursor from flaxseed. Nutr Cancer. 1996;26:159-65.
30. Nesbitt PD, Thompson LU. Lignans in homemade and commercial products containing flaxseed. Nutr Cancer. 1997;29:222-7.
31. McBurney MI, Thompson LU. Effect of human fecal inoculum on in vitro fermentation variables. Br J Nutr. 1987;58:233-43.
32. Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993;123:1939-51.
33. Canadian Council on Animal Care. Guide to the care and use of experimental animals. Canadian Council on Animal Care: Ottawa, Ontario, Canada, 1984.
34. Niemeyer HB, Honig DM, Kulling SE, Metzler M. Studies on the metabolism of the plant lignans secoisolariciresinol and matairesinol. J Agric Food Chem. 2003;51:6317-25.
35. Sicilia T, Niemeyer HB, Honig DM, Metzler M. Identification and stereochemical characterization of lignans in flaxseed and pumpkin seeds. J Agric Food Chem. 2003;51:1181-8.
36. van Oeveren A, Jansen JFGA, Feringa BL. Enantioselective synthesis of natural dibenzylbutyrolactone lignans (-)-enterolactone, (-)-hinokinin, (-)-pluviatolide, (-)-enterodiol, and furofuran lignan (-)-eudesmin via tandem conjugate addition to γ-alkoxybutenolides. J Org Chem. 1994;59:5999-6007.
37. Niemeyer HB, Honig D, Lange-Bohmer A, Jacobs E, Kulling SE, Metzler M. Oxidative metabolites of the mammalian lignans enterodiol and enterolactone in rat bile and urine. J Agric Food Chem. 2000;48:2910-9.
38. Jacobs E, Kulling SE, Metzler M. Novel metabolites of the mammalian lignans enterolactone and enterodiol in human urine. J Steroid Biochem Mol Biol. 1999;68:211-8.
39. Jacobs E, Metzler M. Oxidative metabolism of the mammalian lignans enterolactone and enterodiol by rat, pig and human liver microsomes. J Agric Food Chem. 1999;47:1071-7.
40. Perez C, Almonacid LN, Trujillo JM, Gonzalez AG, Alonso SJ, Navarro E. Lignans from Apollonias barbujana. Phytochemistry. 1995;40:1511-3.
41. Yang SJ, Fang JM, Cheng YS. Lignans, flavonoids and phenolic derivatives from Taxus mairei. J Chin Chem Soc. 1999;46:811-8.
42. Xie LH, Akao T, Hamasaki K, Deyama T, Hattori M. Biotransformation of pinoresinol diglucoside to mammalian lignans by human intestinal microflora, and isolation of Enterococcus faecalis strain PDG-1 responsible for the transformation of (+)-pinoresinol to (+)-lariciresinol. Chem Pharm Bull (Tokyo). 2003;51:508-15.
43. Nesbitt PD, Lam Y, Thompson LU. Human metabolism of mammalian lignan precursors in raw and processed flaxseed. Am J Clin Nutr. 1999;69:549-55.
44. 3H-secoisolariciresinol diglycoside (SDG) metabolites in rats do not differ between acute and chronic SDG treatments. J Nutr. 2000;130:2299-305.
45. Kumagai Y, Wickham KA, Schmitz DA, Cho AK. Metabolism of methylenedioxyphenyl compounds by rabbit liver preparations. Participation of different cytochrome P450 isozymes in the demethylenation reaction. Biochem Pharmacol. 1991;42:1061-7.
46. Fukuda Y, Osawa T, Namiki M. Contribution of lignan analogues to antioxidative activity of refined unroasted sesame seed oil. J Am Oil Chem Soc. 1986;63:1027-31.
47. Tan KP, Chen J, Ward WE, Thompson LU. Mammary gland morphogenesis is enhanced by exposure to flaxseed or its major lignan during suckling in rats. Exp Biol Med (Maywood). 2004;229:147-57.
48. Thompson LU, Rickard SE, Cheung F, Kenaschuk EO, Obermeyer WR. Variability in anticancer lignan levels in flaxseed. Nutr Cancer. 1997;27:26-30.
49. Chen J, Wang L, Thompson LU. Flaxseed and its components reduce metastasis after surgical excision of solid human breast tumor in nude mice. Cancer Lett. 2005; May 20; [Epub ahead of print].
50. Ganry O. Phytoestrogen and breast cancer prevention. Eur J Cancer Prev. 2002;11:519-22.
51. Thompson LU, Chen JM, Li T, Strasser-Weippl K, Goss PE. Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer. Clin Cancer Res. 2005;11:3828-35.